ORTEXORTEX News
Tracking TRN? Get live short interest, options flow, and signals on ORTEX.Sign up free →
TR
Trader NoteTRN

Trainline Heads Into Results With Bulls Firmly in Charge

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 31 Oct 2026, 21:07

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

TRN enters its November 4 results with a clean lending market, a street-level buy consensus, and valuation multiples that still look undemanding, yet the stock slipped 2.6% this week to 205.4p, leaving investors wondering whether the modest pullback is noise or a warning ahead of the print.

The lending market offers almost no signal of bearish conviction. Availability is near its theoretical maximum, with the borrow pool vastly exceeding the shares actually lent out and short interest utilisation running at just 0.23%. Cost to borrow has edged up about 10% this week to 0.65%, but in absolute terms that remains trivial. There is no squeeze pressure, no evidence of a short-seller thesis building, and no tightening trend of any consequence. The short score has drifted marginally lower this week to 45.4 from 46.9, sitting just below the midpoint of its range. The borrow market, in short, is relaxed.

The Street is considerably more constructive than that neutral short score might imply. Nine analysts have a buy rating versus just two holds, and the consensus target of 330p implies roughly 60% upside from Friday's close. Factor rankings reinforce the value case: earnings yield and EV/EBIT both rank in the 81st percentile of the universe, meaning Trainline screens as materially cheap on income-based measures relative to peers. The PE multiple is 7.7 times, the EV/EBITDA 5.3 times. The analyst recommendation differential score of just 5 out of 100 flags that the consensus has not been diverging strongly from the market, a potential underappreciation of the bull case rather than a red flag. There have been no rating changes in the past two weeks.

Institutional positioning adds some texture. BlackRock lifted its stake to 8.97% as of end-September. Invesco added more than 8.3 million shares to reach 5.4% of the company, and Aviva Investors built a 5.4% holding as of October 19, adding nearly 3.8 million shares. Three of the top five holders have been net buyers in recent months, which sits alongside the buy-heavy analyst tilt rather than cutting against it. The most recent open-market insider purchase on record was a relatively small buy by a non-executive director in July at 205.8p, almost exactly where the stock trades now.

The one area of genuine watch is earnings history. The two most recent prints both produced muted or slightly negative immediate reactions: the May 2026 results saw the stock fall around 1.9% on the day and extend to a 14% loss over the following week. The August 2026 update went the other way, with a 1.6% gain on the day and 3.4% over five days, but the sample is too small to draw a reliable pattern. What is clear is that the stock does not historically gap dramatically on the day; the bigger moves have developed over subsequent days.

With the November 4 print four days away, the main question is whether the combination of cheap multiples and a crowded buy consensus provides a floor, or whether any revenue or guidance miss reopens the downside seen in May.

Stocks in this article

See the live data behind this article on ORTEX.

Open TRN on ORTEX →

How this article was generated

Generated
31 Oct 2026, 21:08
Data as of
31 Oct 2026, 21:07
Prompt version
v1.0
Data sources
Cost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.